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Background: Intensive interventions on smoking cessation increase abstinence rates. However, few electronic mail
(E-mail) based intensive interventions have been tested in smokers and none in primary care (PC) setting. The aim
of the present study is to evaluate the effectiveness of an intensive E-mail based intervention in smokers attending
PC services.
Methods/design: Randomized Controlled Multicentric Trial. Study population: 1060 smokers aged between 18–70
years from Catalonia, Salamanca and Aragón (Spain) who have and check regularly an E-mail account. Patients will
be randomly assigned to control or intervention group. Intervention: Six phase intensive intervention with two face
to face interviews and four automatically created and personal E-mail patients tracking, if needed other E-mail
contacts will be made. Control group will receive a brief advice on smoking cessation. Outcome measures: Will be
measured at 6 and 12 months after intervention: self reported continuous abstinence (confirmed by cooximetry),
point prevalence abstinence, tobacco consumption, evolution of stage according to Prochaska and DiClemente's
Stages of Change Model, length of visit, costs for the patient to access Primary Care Center. Statistical analysis:
Descriptive and logistic and Poisson regression analysis under the intention to treat basis using SPSS v.17.
Discussion: The proposed intervention is an E-mail based intensive intervention in smokers attending primary care.
Positive results could be useful to demonstrate a higher percentage of short and long-term abstinence among
smokers attended in PC in Spain who regularly use E-mail. Furthermore, this intervention could be helpful in all
health services to help smokers to quit.
Trial Registration: Clinical Trials.gov Identifier: NCT01494246.
Keywords: Smoking cessation, Electronic mail, Clinical trial, Primary health care* Correspondence: cardiocat@gmail.com
2Primary Healthcare Research Unit of Barcelona, Primary Healthcare
University Research Institute IDIAP- Jordi Gol, C/Sardenya 375, entresuelo
08025 Barcelona, Spain
Full list of author information is available at the end of the article
© 2013 Díaz-Gete et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Díaz-Gete et al. BMC Public Health 2013, 13:364 Page 2 of 11
http://www.biomedcentral.com/1471-2458/13/364Background
Health effects among smokers and non-smokers of
tobacco consumption are well-established including
principally respiratory and cardiovascular diseases and
cancer [1]; in fact is one of the leading preventable
causes of death worldwide and mainly in occidental soci-
eties [2]. In Spain, for instance, smoking is the health
problem that causes more mortality and morbidity [3],
and therefore originates one of the higher health costs.
According to the last national survey conducted in Spain
in 2006 the percentage of daily smokers aged 16 or older
was 26.44% [4]. The vast majority of smokers declare a
willingness to quit smoking and approximately 60% have
tried it [3], although only 3 to 5% of them per year
accomplished smoking cessation [3,5,6].
Several cost-effectiveness studies worldwide have
shown that both low and high impact care interventions
to reduce tobacco consumption are cost-effective mea-
sured in cost per year of life gained and quality of life
[3,7]. Moreover, under a public health view probably
these interventions represent the most cost-effective
method to improve population’s health. Minimum advice
on quitting smoking among the general population
achieves an average of 5% cessation per year [8,9]. In
contrast, more intense interventions, can reach more
than 20% of abstinence [10,11]; in general, it is well
established that the more intensive the intervention, the
best rates of smoking cessation are obtained [10]. The
inclusion of those treatments that have demonstrated its
efficacy in systematic reviews and metanalysis, has been
confirmed to be useful [7].
Therapeutic intensive interventions for smoking cessa-
tion have been used in primary care, such as the one of
the ISTAPS study [12], but none have been based in
Information and Communication Technologies (ICTs).
These interventions are based on the hypothesis that
smokers that do not quit smoking but are aware of its
harmful effects underestimate the health risk to due to
its consumption [13]. So, these interventions could pro-
vide motivational feedback to promote risk awareness
and accelerate changes on smoking behavior [14].
Some smokers who quit smoking have been identified
as susceptible to damaging adverse effects of tobacco
consumption or seen seriously threaten his or her
health [15,16].
The vast majority of non-pharmacological use the
Prochaska and DiClemente’s Transtheoretical Model of
Change [17] that describes a succession of stages
(precontemplation, contemplation, preparation, action
and maintenance) each one indicating a different type of
intervention. Other studies in our country have used this
model among diabetic smokers patients attended in pri-
mary care and to confirm smoking abstinence using
cooximetry [18] and another where information gatheredby cooximetry is the main element to motivate smokers to
quit [19].
The use of electronic mail and internet is increasing
worldwide. In Spain, according to the National Statistics
Institute, in 2010, 57% of households had Internet
access; moreover there are 20 million estimated regular
users and those who log at least once a week represent
58.4% of the population (7.1% increase over the previous
year). Seventy-eight percent of the Spanish population
between 16 and 74 uses the electronic mail, with an
increase of those who access it via mobile devices [20].
Internet and E-mail use is also increasing in medicine
and can be mostly useful in appointment citations and
remainders, analytical results, computerized medical his-
tory, prescription refills, regular follow-up and access to
health information. The advantages derived from
professional-patient E-mail communication include: time
and cost saving for hospitals, primary care centers, pri-
mary care professionals and patients (e.g. patients who
frequently travel and sanitary professional of rural areas
can easily contact with physicians and patients respect-
ively) [21,22] and convenience since it does not have a
simultaneous nature (the person can check the messages
at his or her convenience) [21]. Several patients also
refer that E-mail communication can facilitate the con-
tact with the sanitary professional; in face to face inter-
views they could not feel enough comfortable to rise
certain issues or may have forgotten to ask important
questions. Some of them deem a useful and satisfactory
use E-mail communication in a secure and private envir-
onment [21]. A revision undertaken on the impact of e-
therapies, Hsiung concluded that E-mail tracking is
useful if preceded by a personal and direct relationship
with the patient [23]. Finally, in the global crisis context
these types of interventions can diminish visits to the
primary care center. Limitations comprise unwillingness
to use the E-mail, perception of lack of time and experi-
ence to use the new technologies [21,24], an abuse by an
overriding number of messages on non urgent matters,
and the development of a private and secure website and
a specific deontological code could increase the eco-
nomic costs [25].
Internet use in quitting smoking is becoming more evi-
dent, since it is necessary to recruit more smokers to fight
smoking regardless of race or culture [26]. Several studies
have published about the virtual communities in this field
[27] and internet as a support to phone lines (quitlines)
[28]. It has been established that it is a way that enriches
the sanitary professional-patient relationship and that the
dissemination of patient’s successful experiences can im-
prove their self-esteem and generate positive attitudes [25]
although further research is needed [29].
The 2008 the Treating Tobacco Use and Dependence
Guideline, pointed out that online tools to quit smoking
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tential to undertake interventions; results have been
shown to be only favorable if online interventions are
developed in very complex programs or if were carried
out when the help was more intensive among interven-
tion groups than in controls. Nevertheless, it also
encourages depending on those characteristics that
needs to be improved [7]. In Spain, the National Com-
mittee to Prevent Smoking Cessation (CNPT in Spanish)
also supports these types of interventions to help
smokers to quit [3].
Characteristics of smokers who seek help on the Inter-
net to quit smoking were female sex (59%) and younger
individuals. Generally are subjects who are trying to quit
smoking (53%) and search information on how or medi-
cation to quit, whilst those who have already quit search
information on how to face abstinence [30].
Twenty studies have been found to be registered at
Clinical Trial when using keywords: E-mail AND smok-
ing, none undertaken in Primary Care environment with
personalized follow-up (Clinical Trials, 2012). In 2010
the Cochrane library published a revision that included
the most relevant articles on internet interventions for
quitting smoking. Ten out of twenty compared an inter-
net based intervention with others not based on this
media. The revision concluded that personalized and
interactive internet based interventions, especially if
there is an individualized tracking, can be more effective
than those standardized protocols on smoking cessation.
However, long-term smoking cessation is less effective
when using these interventions compared to other inter-
ventions [31].
Te Poel and collaborators published in 2009 a clinical
essay to evaluate the efficacy of an E-mail computer-
tailored smoking cessation intervention. At six months
post intervention 21.5% and 20.4% of intervention group
reported not having smoked in the last 24 hours and in
the 7 days, respectively compared to the control group
(9.8 and 7.8%, respectively); follow-up lost were quite
high in both control and intervention groups [32].
Polosa et al. demonstrated the utility of an E-mail con-
sultation messages in a smoking-cessation program
although the number of included patients was somewhat
low [33]. Lenert and collaborators determined the effect-
iveness of an automated educational E-mail messaging
system individually sent in the framework of smoking
cessation intervention. The OR for quitting smoking among
the intervention group at 30 days post-intervention was 2.6
(95% CI: 1.3-5.3) [34]. An increased smoking and reduced
frequency of smoking was observed in young adults after an
online peer support via E-mail [35] and in adolescents after
a home based internet intervention [36,37].
In Spain there are two online initiatives to help
smokers to quit. The first one, the Madrid City CouncilGiving-up smoking on-line Programme, that combined
automated interaction with the user and personal E-mail
consultations that included 4865 smokers. After the
treatment period the smoking cessation rate was 17.8%
and at six months post intervention the abstinence
achieved was 10% [38]. The second one is undertaken by
the Psychology Faculty of the National Distance Education
University (UNED) but not results have been published
yet [39].
In Barcelona, Spain, the study E-consulta in Primary Care
setting is being undertaken. Its main objective is to develop
a secure web environment for sanitary professional-patient
communication via E-mail (e.g. acute health problems,
laboratory results, health measurement reports, or prescrip-
tion refills) to avoid unnecessary face to face visits. The
sanitary professional committed to answer patients E-mail
on the following 48 working hours. The study is carried out
in twelve primary care centers and includes 19 physicians,
16 nurses and 647 patients. This initiative has been posi-
tively evaluated by both sanitary professionals and patients
and it is planned to spread it to all territorial setting [40].
Both, The E-consulta and the experience described by
Wallwiener and collaborators in 2009 [22,40], allow to
think that better service and satisfaction of primary care
services will be achieved by reducing resources of pri-
mary care addressed to smoking cessation. If sanitary
systems facilitated E-mail based interventions on smok-
ing cessation, and other sanitary problems, costs could
be reduced and medical care and patient and sanitary
professional satisfaction could be improved.
Methods/Design
Study design
A randomized controlled multicentric trial to evaluate
the effectiveness and the cost effectiveness of a clinical
practice guide based intervention, based in six contacts
(two face to face interviews and 4 E-mails), to obtain
continued smoking abstinence at 6 and 12 months com-
pared to brief advice in smokers attended in Primary
Care.
Study population
Inclusion criteria of participants will comprise: smokers
(of at least one cigarette per day) aged between 18 and
70 years who have an electronic mail account and check
it regularly (at least once a week) and can assure their
participation in the study for a year.
Exclusion criteria will be based on certain medical
conditions which could contraindicate the fulfillment of
the intervention such as known terminal illnesses, severe
mental diseases, addiction to other psychoactive sub-
stances, patients that have already started to quit smok-
ing or those unwilling to participate in the study were
excluded. Smokers who do not have an E-mail account
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well as those smokers who do not wish to be followed
via E-mail as prefer face to face contacts.
Written informed consent will be obtained from all
subjects of both intervention (IG) and control group
(CG) prior to its inclusion on the study.
Recruiting process
Inclusion of sanitary professionals
Diffusion of the project will be made in all primary care
centers of the study area through the Xarxa de Centres
Sense Fum (network of smoke free centers) to obtain
sanitary professionals (general practitioners and nurses)
interested in recruiting patients for the study. Of those
willing to participate we will select only those who are
regular users of E-mail and will be asked to sign a par-
ticipation commitment. Causes of refusal to participate
will be recorded. Those professionals interested in par-
ticipating will attend a two-hour formative activity where
the aim, methods, intervention will be explained and will
be trained in the management of project’s web page and
cooximetry technique. Assistance to one of the ten for-
mative activities scheduled at different times to facilitate
professional attending will be mandatory to participate
in the study.
Inclusion of participants and randomization
During the recruitment period (first semester of 2013),
trained professionals of each primary health care centre
(general practitioners or nurses) will invite to participate
subjects who meet the inclusion criteria by random sys-
tematic procedures. Twice a week each professional will
invite to participate the first two smokers aged 18 to 70
who consulted them for any reason. In order to follow the
criteria specified in the CONSORT Guide, we will register
for all the subjects invited to participate (included or not
in the study) on the web page of the study: date of inter-
view, professional who realizes the visit, age and sex of the
participant, and consumption of tobacco. Causes of refusal
to participate will be recorded. Written informed consent
to participate in the present study will be asked to all the
individuals who accept to participate. Afterwards, the
system of randomization of patients in control and inter-
vention group (1:1 ratio) will be centralized and computer
generated. Figure 1 shows the flow chart of the study.
Description of the intervention
Control group
Subjects assigned to the control group, once the motiv-
ating problem of the clinical visit had been solved, will
receive a brief advice on quitting smoking. Three
months after the intervention a second face to face
interview will be done to this group to check tobacco
abstinence.Intervention group
The proposed intervention will consist in the application
of the recommendations of Miltenberger [41] and an
evidence-based practical clinical guideline of the Primary
Care Division of the Catalan Institute of Health [42].
Both propose an intervention previous to the day the pa-
tient sets to stop smoking (D-day) to reinforce behavior,
to follow the patient a week after the D-day since ap-
proximately 25% of smokers who attempt to quit relapse
within the first week and an E-mail feedback to reinforce
behavior, to praise positive achievements (such as cigarette
consumption reduction) and provide simple corrective
feedback when the patient does not perform the target be-
havior. The basic steps on the intervention are:
1. First face to face interview: In the first contact with
the patient, sociodemographic and related to
tobacco consumption variables will be collected
using a structured face to face interview. E-mail
tracking will be approximately set for those
individuals in the preparation/action stage, according
to the model defined by Prochaska and DiClemente.
2. First E-mail contact: Will be done the following day
from the first face to face interview in order to
establish the day the individual will stop smoking
(D-day), the treatment (if needed), to assess and
facilitate motivational support to achieve individual’s
goal to quit smoking.
3. Second E-mail tracking: Will be done a week later of
D-day to evaluate abstinence, tolerance and adverse
effects of medication, difficulties in everyday life, and
to control medication.
4. Third E-mail tracking: Will be done 10 to 15 days
after D-day to evaluate abstinence, gained benefits,
to prevent relapsed and to control medication.
5. Fourth E-mail tracking: Will be done a month after
D-day to prevent relapsed and false securities, to
evaluate obtained benefits and to control
medication.
6. Second face to face interview: Will be done three
months after D-day to finish the treatment, to
emphasize the effort made and improvement in
patient conditions and to stress and prevent possible
relapses. On those who declare tobacco abstinence
an analysis of exhaled carbon monoxide (CO) will be
made by cooximetry in standard conditions to
confirm it.
The six phases of the intervention will be made on
those patients who fix the D-day by the same sanitary
professional who made the first contact with the patient
and usually is the one who gives him/her attention, inde-
pendently if he or she is a general practitioner or a
nurse. E-mail messages will be automatically created by
Assessed for eligibility (n=)
Initial face to face interview (n=)
Excluded (n=):
Not meeting inclusion criteria (n=)







Allocated to intervention (intervention 
group) (n=)
Received allocated intervention (n=  )
Did not receive allocated intervention (e.g. 
dropouts) (n=)
























Telephone follow-up at six months post
brief advice** (n=)
Discontinued follow-up (reasons) (n=)
Telephone follow-up at twelve months 
post-intervention** (n=)
Discontinued intervention (reasons) (n=)
Telephone follow-up at twelve months 
post brief advice** (n=)
Discontinued follow-up (reasons) (n=)
Telephone follow-up at six months post-
intervention** (n=)
Discontinued intervention (reasons) (n=)
Face to face interview at three months 
post-intervention** (n=) 
Discontinued intervention (reasons) (n=)
Allocated to brief advice on smoking 
cessation (control group) (n=)
Received allocated intervention (n=  )
Did not receive allocated intervention (e.g. 
dropouts) (n=)
Face to face interview at three months 
post brief advice** (n=) 








Figure 1 Algorithm of the TABATIC study. ** A confirmatory cooximetry in standard conditions will be done on those subjects that declare
tobacco abstinence. * Those individuals who are not willing to fix the D-day (usually in contemplative and precontemplative stages) will be
contacted only once via E-mail after a month of the first face to face interview to encourage them to quit smoking. The patient will be able to fix
the D-day up to 15 days prior to the second face to face interview.
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the patient, information on the visits, the D-day (if fixed)
and the name of the sanitary professional. Besides, the
above established E-mail tracking, other E-mail contacts
will be made, if needed, in order to clarify subject’s pos-
sible doubts (such as medication queries). Nature of the
E-mails of the intervention o the study is offered in
Additional file 1.
Those individuals who are not willing to fix the D-day
(usually in contemplative and precontemplative stages)
will be contacted only once via E-mail after a month ofthe first face to face interview to encourage them to quit
smoking. A specific E-mail message will be sent to those
who refer a lapse. The patient will be able to fix the D-
day up to 15 days prior to the second face to face
interview.
The study web page will be developed and maintained
by an external company that will also offer support dur-
ing the intervention process. In order to ensure confi-
dentiality, we will assign to each participant his/her user
identification and password so he or she will be able to
read the electronic messages and reply if necessary.
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tion code and password and will have only access to
their own patient’s information. Moreover the study web
page will be accredited as secure web environment in
accordance to the national current legislation.
Both groups, control and intervention, will be followed
at six and twelve months after the intervention by
phone. The calls will be made by trained monitors of an
external company who will not know if the patient be-
longs to control or intervention group, and will include
a brief structured questionnaire to know their tobacco
consumption, their stage of change and tobacco abstin-
ence. A confirmatory cooximetry in standard conditions




Self reported ‘continuous abstinence’ defined by Hughes
et al. 2003 [43] as the abstinence between quit day and a
follow-up time (at six and twelve months) after interven-
tion confirmed by a breath CO cooximetry concentration
of 6 parts per million (ppm) or less in standard conditions.
Other outcome measures:
– Point prevalence abstinence according to Hughes
et al. 2003 [43] defined as prevalence of abstinence
during a time window immediately preceeding
follow-up at three, six and twelve months after
intervention confirmed by breath carbon monoxide
cooximetry in standard conditions.
– Self reported tobacco consumption at three, six and
twelve months after intervention: daily consumption
in cigarettes/day.
– Self-reported reduction of daily tobacco
consumption in cigarettes/day when the subject
does not stop smoking at three, six and twelve
months after intervention.
– Change of stage in the Prochaska and DiClemente's
Stages of Change Model at three, six and twelve
months after intervention.
– Prescription of tranquilizers, antidepressants, NRT
(nicotine replacement therapy), at the beginning and
end of the intervention and six and twelve months
post intervention.
– Registered use of sanitary services in primary and
specialized care, both in public and private settings.
– Time used by professionals in the two face to face
interviews (initial and three months visits).
– Time used by sanitary professionals in case they
have to answer E-mail contacts.
– Time used by patients in case they have to ask
questions during the E-mail intervention.– Costs for the patients to access Primary Care service
at three, six and twelve months after intervention.
Independents:
– Type of intervention: Intensive counseling by E-mail
vs brief advice.
Data collection
At baseline visit, face to face interview with the sanitary
professional will be carried out and the following infor-
mation will be registered:
– Socio-demographic characteristics: age, gender, civil
status, educational level, social class according to the
classification of the UK Registrar General's social
classification (RGSC).
– E-mail frequently used and data for the telephone
tracking.
– Characteristics of individual's tobacco consumption:
daily consumption in cigarettes/day, years of
smoking, age at the start, time before first cigarette
of the day, nicotine, dependence measured by the
Fagerström test [44], number of previous attempts
to quit smoking, maximum time of abstinence,
pharmacological treatment used on previous
attempts to quit smoking: type, timetable, side
effects, family and friends environmental tobacco
consumption, partner interaction questionnaire (PIQ
Test) to measure of spouse/partner support related
to cessation [45].
– Change of stage in the Prochaska and DiClemente's
Stages of Change Model.
– Alcohol consumption.
– Morbidity (related or not to tobacco consumption):
chronic obstructive pulmonary disease,
cerebrovascular event, ischemic cardiopathy, arterial
hypertension, hypercholesterolemia, cancer and
peripherical arteriopathy, diabetes mellitus, obesity.
– Weight.
– Breath carbon monoxide (CO) in ppm measured by
cooximetry which will be carried out by trained
health professionals using following a pre-established
protocol.
At three months after intervention a second face to face
interview will be undertaken with the sanitary professional
and the following information will be recorded: time spent
in the visit and if the subject currently smokes. If so, daily
consumption in cigarettes/day and stage of change
according to Prochaska and DiClemente's Stages of
Change Model will be recorded. If not, date of smoking
cessation, time (in days) of abstinence will be asked, and
level of breath CO by cooximetry in standard conditions.
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Date of visit and the professional who undertakes it will be
additionally recorded.
At six and twelve months after intervention all partici-
pants will be asked by phone about some variables related
to tobacco consumption and stage of change in the
Prochaska and DiClemente's Stages of Change Model (de-
scribed above) by trained monitors. Moreover, at twelve
months after intervention, level of satisfaction, acceptance
of intervention, number of E-mail messages written and
number of replies and level of social support during the
intervention measured by PIQ Test will be recorded.
Data management and quality assurance
In order to guarantee and to ensure the quality of the
study, data to maximize validity and reliability the
following measures will be employed:
 Written documentation and electronic data
collection: Written copies of protocols and consent
forms will be printed and stored in the study web
page. All data will be registered in the electronic
data collection system developed and maintained
specifically for this study by an external company to
assure consistency. Regular backups will be
performed and transferred to the central database as
well as random checks of data entry. If needed,
corrections will be made by checking paper records
or, in rare cases, by phoning participants for
confirmation by independent investigators.
 In order to guarantee the correct registration of
data, a training session will be made to all sanitary
professionals who participate in the study in the
intervention and the use of the electronic data
collection system. The contents of the training
sessions will be evaluated by completing a
standardized evaluation form to ensure the
consistency of the program.
 Regular meetings and mailings between members of
the study group (the TABATIC team) and all
participating centers. Furthermore, a person has
been contracted part-time to provide technical and
methodological support to all investigators of the
study via E-mail or telephone.
 Telephone interviewers will be trained on
characteristics and procedures of the study.
Sample size
Accepting an alpha risk of 0.05 and a beta risk of 0.20 in a
bilateral contrast, 1060 individuals are needed; 530 individ-
uals in the IG and 530 in the CG in order to detect a differ-
ence of at least a 5% among both groups. A continued
abstinence of 5% was assumed for the non intervention
group and a dropout rate of 20% is estimated. The samplesize calculations were performed with the Granmo pro-
gram (version 7.1).
Statistical methods
Data will be analyzed in concordance with the Consort
Cluster guide [46], and all analyses will be done on an
intention to treat basis. Baseline descriptive statistics
among CG and IG in relation to the variables studied will
be computed as customary; in contingency tables Pearson’s
Chi-square test for independence or homogeneity will be
applied to assess the relationship between two categorical
variables, T-Student test or ANOVA will be used in the
comparison of means if the variables follow a normal dis-
tribution and U of Mann Whitney test if they do not. For
the other dimensions of the analysis, a covariance analysis
(ANCOVA) for repeated measures will be carried out.
A multilevel logistic regression and a Poisson regression
will be done to evaluate the association between each of
the dependent variables and the independent variables that
have resulted statistically significant in the bivariate ana-
lysis. All analysis will be adjusted for potential confounding
factors and for variables with clinical relevance. The level
of statistical significance will be set at 0.05, and all tests will
be two-tailed. Statistical analyses will be conducted using
SPSS, version 17.0 (SPSS Inc, Chicago, IL).
Cost analysis
A cost-effectiveness analysis will be also undertaken under a
societal perspective to compare the cost of the new interven-
tion versus the usual care, to know the clinical effectiveness
and the resource savings for the National Health System
[47]. Subsequently, a deterministic sensitivity analysis will be
performed to assess the robustness of the results [48].
Ethical approval
This study has been reviewed and approved by the Clinical
Investigation Ethics Committee of the IDIAP Jordi Gol,
located in Barcelona, Spain and registered at Clinical Trials
(code number: P11/41). The participation in this study is
strictly voluntary and withdrawal will not have any conse-
quence on the management of the subject illness, which will
be carried out rigorously following the accepted international
norms. The data will be treated confidentiality according to
the Organic Law which regulates the confidentiality of com-
puterized data (Personal data Protection Law 15/1999); only
the investigators and monitors/auditors of the study will have
access to the data of the subjects who agreed to participate.
Associated studies
We are currently undertaking two associated studies to the
TABATIC Project. The first, a descriptive one aims to
know the availability and use of Communication and Infor-
mation Technologies among smokers attended in primary
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riers and facilitators of Communication and Information
Technologies to help smokers to quit, that both, smokers
and health professionals who help patients to quit smok-
ing, refer.
Discussion
The proposed intense intervention consists in the appli-
cation of the recommendations of an evidence-based
practical clinical guideline of the Primary Care Division
of the Catalan Institute of Health [42] based in six con-
tacts (two face to face interviews and 4 E-mails), to
obtain continued smoking abstinence at 6 and 12
months. There are some international studies that use
E-mail based interventions to help smokers to quit, but
none has the same characteristics as the one proposed
[5,10,26,27,32-35,37,49]. Furthermore, to our best know-
ledge, in Spain there are no studies that use this type of
interventions at any level of clinical services.
Since the implementation in 2006 of the law 28/2006
for smoking prevention, the number of primary care con-
sultations regarding smoking cessation has been raised,
subsequently an approach to smoking cessation should be
a key essential objective of both the clinical practice and
public health research. Subsequently, primary care is an
ideal setting to develop a health counseling E-mail pro-
gram based on a practical clinical guideline due to its al-
most universal coverage in Spain [3,50]; it is estimated
that 75% of the population visits his or her general practi-
tioner at least once a year, and that people who smoke do
so more often than non-smokers [3,51].
One of the main strengths of the TABATIC project is
that, to our best knowledge, for the first time the thera-
peutic use of E-mail tracking will be evaluated in order to
help smokers to quit. Furthermore, the same sanitary pro-
fessional, who habitually attends the patient and with
whom a previous confidence relationship has been
established, is the one who follows the patient during this
intervention which can lead to more successful outcomes
if compared to other more impersonal follow-up interven-
tions such as web pages or community programs [31]. An-
other strength of E-mail tracking interventions according
to Kuppersmith is its asynchronous nature; E-mail commu-
nication allows physician and patient not to be available at
the same time. In addition, both can access at their
messages at their own convenience and as many times as
needed [21]. Moreover, this type of intervention could re-
duce social and sanitary costs due to its great accessibility,
its capability to diminish trips and timeouts to be attended.
Selection bias among health care professionals may
occur since those who volunteered to participate could
be more motivated than other sanitary professionals.
Randomization will be made among smokers and not in
primary care centers which will lead to use this E-mailintervention in only some of his or her patients; however
the randomization will be previously automatically cre-
ated so the professional will not be able to decide on
which patients should use the intervention since it will
be computer generated. Patients assigned to the control
group will receive a brief advice on quitting smoking.
One of the main limitations of the study is that we will
only include professionals who know how to use com-
puters and E-mail and can assure participation in the
study by using it. However we feel confident that an im-
portant number of participating professionals will run
correctly the program since most of them have previ-
ously participated in other complex tobacco studies
undertaken in our territory such as the ISTAPS (176
basic care units that worked in 82 Spanish primary care
centers; participants: 2,827 smokers aged 14–85 years),
ITADI (400 professionals and 1077 diabetic smokers)
and BIBE studies (162 pediatric teams from 96 Spanish
primary care centers; participants: 1101 child) [12,18,52].
No economic compensation will be offered to sanitary
professionals; consequently, those who expect to be re-
imbursed for this extra activity will be also excluded of
the study. Some professionals may be reluctant to use
electronic mail in professional health care-patient com-
munication. Reasons to be reluctant may include the
believe that written messages can omit important conno-
tations in communication (such as body language or
voice tone), the concern that individuals may send a vast
number of irrelevant messages and the possible dissem-
ination of health professional e-mail address [21,53]. To
assure health care professional and patient confidential-
ity, an external company will develop and maintain the
study a secure web page; if needed, they will control and
limit each subject web page use [54]. We are currently
carrying out a qualitative study in order to describe
possible barriers and facilitators of Information and Com-
munication and Technologies to help smokers to quit.
If the proposed intervention is effective, it should be
adapted to the informatics systems of each local health
service.
The present trial aims to show the effectiveness of an E-
mail smoking cessation intervention based in the recom-
mendations of an evidence-based clinical practice guide-
line of the Primary Care Division of the Catalan Institute
of Health at six and twelve months post-intervention [42].
The goal is to propose a new and effective intervention in
primary care, as well as in other sanitary settings, as a
complementary tool to treat smokers.Additional file
Additional file 1: Nature of the E-mails of the intervention of the
TABATIC study.
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